REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new ...
Qiagen (QGEN) announced the launch of Ingenuity Pathway Analysis Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Leveraging AI technology, ...
Ingenuity Systems has announced that they have expanded the terms of their existing agreement with Daiichi Pharmaceutical Co., Ltd. for access to the Ingenuity Pathways Analysis software. Ingenuity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results